Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.
Lopetuso, Loris Riccardo; Petito, Valentina; Graziani, Cristina; Schiavoni, Elisa; Paroni Sterbini, Francesco; Poscia, Andrea; Gaetani, Eleonora; Franceschi, Francesco; Cammarota, Giovanni; Sanguinetti, Maurizio; Masucci, Luca; Scaldaferri, Franco; Gasbarrini, Antonio.
; 36(1): 56-65, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-28683448
New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases.
Alterations of the human gut Methanobrevibacter smithii as a biomarker for inflammatory bowel diseases.
Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome.
Gut microbiota as potential orchestrators of irritable bowel syndrome.
Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating.
[Comparison of gut microbiotal compositional analysis of patients with irritable bowel syndrome through different bioinformatics pipelines].
Systematic review and comparison of national and international guidelines on diverticular disease.
Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.
Giardia duodenalis induces paracellular bacterial translocation and causes postinfectious visceral hypersensitivity.
Probiotics in Irritable Bowel Syndrome: The Science and the Evidence.